{
  "name" : "dacemirror.sci-hub.se_journal-article_ba4dd21d8d0d603a1bd3719d471f39e3_xiao2019.pdf",
  "metadata" : {
    "source" : "META",
    "title" : "The Nanoassembly of an Intrinsically Cytotoxic Near‐Infrared Dye for Multifunctionally Synergistic Theranostics",
    "authors" : [ "Ya-Fang Xiao", "Fei-Fei An", "Jia-Xiong Chen", "Jia Yu", "Wen-Wen Tao", "Zhiqiang Yu", "Richard Ting", "Chun-Sing Lee", "Xiao-Hong Zhang" ],
    "emails" : [ "anfeifei@xjtu.edu.cn", "yuzq@smu.edu.cn" ],
    "sections" : [ {
      "heading" : null,
      "text" : "FULL PAPER\n1903121 (1 of 12) © 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim\nwww.small-journal.com"
    }, {
      "heading" : "The Nanoassembly of an Intrinsically Cytotoxic",
      "text" : ""
    }, {
      "heading" : "Near-Infrared Dye for Multifunctionally Synergistic",
      "text" : ""
    }, {
      "heading" : "Theranostics",
      "text" : "Ya-Fang Xiao, Fei-Fei An,* Jia-Xiong Chen, Jia Yu, Wen-Wen Tao, Zhiqiang Yu,*"
    }, {
      "heading" : "Richard Ting, Chun-Sing Lee, and Xiao-Hong Zhang*",
      "text" : "Dr. F.-F. An Institute of Medical Engineering Department of Biophysics School of Basic Medical Science Health Science Center Xi’an Jiaotong University No.76 Yanta West Road, Xi’an 710061, Shaanxi, P. R. China E-mail: anfeifei@xjtu.edu.cn Prof. Z. Yu Guangdong Provincial Key Laboratory of New Drug Screening School of Pharmaceutical Sciences Southern Medical University Guangzhou 510515, P. R. China E-mail: yuzq@smu.edu.cn Prof. R. Ting Department of Radiology Molecular Imaging Innovations Institute Weill Cornell Medicine New York, NY 10065, USADOI: 10.1002/smll.201903121\n1. Introduction\nIt has been confirmed that hyperthermia is lethal for living cells when the temperature rises over 50 °C, thus, photothermal therapy (PTT) has attracted much attention in recent years.[1,2] Up till now, many nanomaterials, such as noble metal (e.g., Au, Pd) nanoparticles,[3] transition metal dichalcogenides (e.g., MoS2, WS2 nanosheets, and CuS2) nanoparticles,[4] carbon nanomaterials (e.g., nanographene and carbon nanotubes)[5] as well as near infrared (NIR) organic dyes and polymers[6] have been explored as photothermal nanoagents. The mass extinction coefficient is one of the important indicators to evaluate the photothermal converting performance of the photothermal nanoagents, which makes it attractive to explore nanomaterials with ultrahigh mass extinction coefficient.[7]\nFurthermore, their combination with chemotherapy is also intensely explored to improve cancer treatment outcome by synergistic effect.[8] The combined chemo and photothermal therapy has been shown to The combination of diagnostic and therapeutic functions in a single theranostic nanoagent generally requires the integration of multi-ingredients. Herein, a cytotoxic near-infrared (NIR) dye (IR-797) and its nanoassembly are reported for multifunctional cancer theranostics. The hydrophobic IR-797 molecules are self-assembled into nanoparticles, which are further modified with an amphiphilic polymer (C18PMH-PEG5000) on the surface. The prepared PEG-IR-797 nanoparticles (PEG-IR-797 NPs) possess inherent cytotoxicity from the IR-797 dye and work as a chemotherapeutic drug which induces apoptosis of cancer cells. The IR-797 NPs are found to have an ultrahigh mass extinction coefficient (444.3 L g−1 cm−1 at 797 nm and 385.9 L g−1 cm−1 at 808 nm) beyond all reported organic nanomaterials (<40 L g−1 cm−1) for superior photothermal therapy (PTT). In addition, IR-797 shows some aggregation-induced-emission (AIE) properties. Combining the merits of good NIR absorption, high photothermal energy conversion efficiency, and AIE, makes the PEG-IR-797 NPs useful for multimodal NIR AIE fluorescence, photoacoustic, and thermal imaging-guided therapy. The research exhibits the possibility of using a single ingredient and entity to perform multimodal NIR fluorescence, photoacoustic, and thermal imaging-guided chemo-/photothermal combination therapy, which may trigger wide interest from the fields of nanomedicine and medicinal chemistry to explore multifunctional theranostic organic molecules."
    }, {
      "heading" : "Nanotheranostics",
      "text" : "Y.-F. Xiao, Dr. J.-X. Chen, J. Yu, W.-W. Tao, Prof. X.-H. Zhang Jiangsu Key Laboratory for Carbon-Based Functional Materials & Devices Institute of Functional Nano & Soft Materials (FUNSOM) Joint International Research Laboratory of Carbon-Based Functional Materials and Devices Soochow University 199 Ren’ai Road, Suzhou 215123, Jiangsu, P. R. China E-mail: xiaohong_zhang@suda.edu.cn Y.-F. Xiao, Dr. J.-X. Chen, Prof. C.-S. Lee Center of Super-Diamond and Advanced Films (COSDAF) and Department of Chemistry City University of Hong Kong Hong Kong SAR, P. R. China\nThe ORCID identification number(s) for the author(s) of this article can be found under https://doi.org/10.1002/smll.201903121.\nSmall 2019, 1903121\n1903121 (2 of 12)\nwww.advancedsciencenews.com\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim\nwww.small-journal.com\nbe particularly effective for controlling cancer micrometastasis and reducing the possibility of cancer recurrence.[9] Such bimodal therapies are typically achieved by co-loading or integration of chemotherapeutic drug and photothermal converting agent in a single nanoparticle.[10] It has been rarely explored for a nanomedicine composed of a single organic molecule possessing both NIR photothermal therapy and intrinsic cancer cell killing abilities.\nHerein, we report a multifunctional theranostic nanoagent, PEG-IR-797 nanoparticle (PEG-IR-797 NP), which was fabricated by IR-797 molecular self-assembly and further modification with an amphiphilic polymer C18PMH-PEG5000 to increase its stability in the biological environment (Scheme 1). The fabricated PEG-IR-797 NPs can act as a chemotherapeutic agent because IR-797 molecules are released and induce the death of cancer cells intrinsically via apoptosis mechanism. The apoptosis mechanism was demonstrated by western blot analysis on the expression levels of apoptosis related proteins, which revealed the upregulation of pro-apoptotic proteins (p53, caspase3, Bax, Bak, and Bad) and downregulation of anti-apoptotic proteins (Bcl-xL and Bcl-2). PEG-IR-797 NP was also found to have an ultrahigh mass extinction coefficient of 205.2 L g−1 cm−1 at 797 nm and 178.2 L g−1 cm−1 at 808 nm inherent from that of the IR-797 molecule (444.3 L g−1 cm−1 at 797 nm). With a high photothermal conversion efficiency of 56.16%, the PEG-IR-797 NPs possess the extraordinary ability of heat generation under 808 nm laser irradiation for photothermal therapy. With the intrinsic abilities of both PTT and chemotherapy of IR-797 molecules, PEG-IR-797 NPs that are self-assembled from IR-797 molecules could achieve the synergistic combination therapy effect both in vitro and in vivo. Benefiting from the strong absorbance over the NIR region, the PEG-IR-797 NPs display not only excellent photothermal effect but also the significant abilities of multimodal photoacoustic, NIR fluorescence and photothermal imaging for tumor\ndiagnosis, and guiding the light irradiation during PTT. The aggregation-induced emission (AIE) property of IR-797 makes the PEG-IR-797 NPs favorable for the high-contrast fluorescence imaging on tumors. Thus, the PEG-IR-797 NPs that possess intrinsic cytotoxicity, excellent photothermal effect, multimodal NIR fluorescence/photoacoustic/photothermal imaging would be promising for both precise photothermal therapy by multimodal imaging-guided laser irradiation and improved cancer therapy outcome by synergistic chemo-/photothermal combination therapy."
    }, {
      "heading" : "2. Results and Discussion",
      "text" : ""
    }, {
      "heading" : "2.1. Preparation and Characterization of IR-797 NPs and PEG-IR-797 NPs",
      "text" : "The IR-797 molecule is hydrophobic and thus the IR-797 NP could be prepared via solvent exchange method. IR-797 was dissolved in CH3CN to form a stock solution, which was added into deionized (DI) water dropwise under vigorous magnetic stirring. Then, the acetonitrile and free IR-797 were removed using dialysis bags (cutoff = 3.5 kDa) against deionized water. The UV–vis absorption of IR-797 of 0.0024 × 10−3 m is measured to be 0.539 at 797 nm. According to the Lambert–Beer law and the molecular weight of IR-797, the maximum mass extinction coefficient of IR-797 NPs is calculated as 444.3 L g−1 cm−1 at 797 nm (Figure 1a), which is ultrahigh among most reported photothermal converting nanomaterials (Table S1, Supporting Information). To enhance the stability of hydrophobic IR-797 NPs in an aqueous environment, an amphiphilic polymer synthesized in our previous work,[11] C18PMH-PEG5000, was used to modify IR-797 NPs to obtain the PEG-IR-797 NPs (Scheme 1b). The Stokes Shift of PEG-IR-797 NPs is ≈20 nm (calculated as\nSmall 2019, 1903121\nScheme 1. a) The multiple functions of PEG-IR-797 NPs achieved in cancer theranostics. The terms of PTT, FLI, PAI, CHEMO, and TI stand for photothermal therapy, fluorescent imaging, photoacoustic imaging, chemotherapy, and thermal imaging, respectively. b) Illustration of preparation of PEG-IR-797 NPs. 1) To evaporate the acetonitrile (CH3CN) by stirring overnight and then dialyzed with 3.5 kDa MWCO membrane for 4 h to remove CH3CN and free IR-797. 2) Adding C18PMH-PEG5000/DI H2O solution in purified IR-797 NPs suspensions and stirred for 24 h. 3) After stirring, the IR-797 NPs are coated with C18PMH-PEG5000 and purified with a Millipore filter. c) The chemical structures of C18PMH-PEG5000 and IR-797 chloride.\n1903121 (3 of 12)\nwww.advancedsciencenews.com\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim\nwww.small-journal.com\nthe difference between the wavelength of maximum absorption and the wavelength of maximum emission Figure 1b). A small Stokes Shift indicates high light self-absorption and intense production of heat from the self-absorbed light. Transmission electron microscopy (TEM) and scanning electron microscope (SEM) images of PEG-IR-797 NPs show nanospherical morphology with diameters of 70–90 nm (Figure 1c). The SEM and TEM images of IR-797 NPs are also provided in Figure S1 in the Supporting Information. The sizes of both PEG-IR797 NPs and naked IR-797 NPs in deionized water were also measured by the dynamic light scattering (DLS). Due to the hydration effect of PEG, the size of PEG-IR-797 NPs (≈92 nm) is larger than that of naked IR-797 NPs (≈68 nm) in deionized water (Figure 1d). The size of PEG-IR-797 NPs is suitable for tumor accumulation via an enhanced permeability and retention (EPR) effect.[12] Compared with naked IR-797 NPs, PEGIR-797 NPs exhibit an excellent size-stability in 1× phosphate buffer saline (PBS) (pH 7.4) over 72 h (Figure 1e). In the inserted photo of Figure 1e, PEG-IR-797 NPs suspension (left) is relatively more stable than IR-797 NPs suspension (right) which generates visible flocculent precipitate in the tube after 72 h. The stability of the PEG-IR-797 NPs in different mediums (deionized water, 1× PBS, 1× PBS + 10% FBS, DMEM and DMEN + 10% FBS) was also studied by measuring the size of nanoparticles. The results showed no obvious size change over 72 h, which indicates the excellent stability of the PEG-IR797 NPs in various biological media and suitability for in vivo applications (Figure S2, Supporting Information). The zeta potential of PEG-IR-797 NPs is −42.5 ± 2.98 mV, while that of IR-797 NPs is 37.4 ± 3.65 mV (Figure S3, Supporting Information). Negatively charged nanoparticles can reduce the aggregation and adhesion to various proteins in the blood, which prolongs their blood circulation. Unexpectedly, IR-797 molecule exhibits AIE effect that the fluorescence increases more than ninefold in 99% DI water compared with that in 100% CH3CN. The maxima of emission spectra of IR-797 NPs and PEG-IR-797 NPs were measured in the CH3CN/DI water mixture with different fractions of water (fw) (Figure 1f). The whole fluorescence spectra of IR-797 NPs and PEG-IR-797 NPs are shown in Figure S4a,b in the Supporting Information. The IR-797 NPs show stronger fluorescent enhancement than PEG-IR-797 NPs due to the absence of PEG modification. The AIE property can be attributed to the decreased opportunity of collision between solvent molecule and IR-797 molecule.[13] It is known that this collision is extremely sensitive for NIR molecules which possess small energy gap and easily lose energy during the collision. As shown in Figure S5 in the Supporting Information, when IR-797 dissolves in a good solvent, it will collide with solvent molecule in a great collision probability, during which, IR-797 molecules lose their energy to the solvent and lead to poor fluorescence. While in the nanoaggregates, only molecules on the surface can collide with the solvent molecules and the collision probability of solvent molecule and IR-797 molecule reduced, which may result in the decrease of energy\nSmall 2019, 1903121\n1903121 (4 of 12)\nwww.advancedsciencenews.com\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim\nwww.small-journal.com\nloss, and thus intensify the fluorescence emission. The fluorescence of IR-797 molecule was also tested in the mixed solvents of DI water/dimethyl sulfoxide (DMSO) and DI water/ethanol (EtOH) with different fractions of DI water, which shows similar results of fluorescence enhancement at aggregated state (Figure S6a,b,d,e, Supporting Information)."
    }, {
      "heading" : "2.2. Photothermal Properties of the PEG-IR-797 NPs",
      "text" : "The excellent light absorption ability in the NIR wavelength range and ultrahigh mass extinction coefficient endow PEG-IR-797 NPs with the excellent properties of NIR photothermal effect, fluorescence imaging, and photoacoustic imaging. The mass extinction coefficient of PEG-IR-797 NPs is 205.2 L g−1 cm−1 at 797 nm and 178.2 L g−1 cm−1 at 808 nm and calculated from the absorption spectrum in Figure S7 in the Supporting Information. The photothermal heating curves of PEG-IR-797 NPs at different concentrations in 1× PBS (pH 7.4) were recorded under the 808 nm laser irradiation (1 W cm−2) for 8 min (Figure 2a,b). With extraordinary photothermal effect, PEG-IR-797 NPs reach 55 °C within 3 min at a concentration of 35.4 mg L−1 (0.07 ×10−3 m). The peak temperatures reached with different concentrations of PEG-IR-797 NPs were measured. According to Figure S8a in the Supporting Information, 0.05 × 10−3 m (25 mg L−1) PEG-IR-797 NPs could reach 50 °C at peak temperature, which is a high enough temperature to kill cancer cells.[2] The heating curves of PEG-IR-797 NPs and IR-797 NPs at the same concentration of 0.07 × 10−3 m were measured (Figure 2c). Compared with IR-797 NPs, PEG-IR-797 NPs has a higher peak temperature at the same concentration because of its larger ratio of nonradiative transition (energy loss\nSmall 2019, 1903121\n1903121 (5 of 12)\nwww.advancedsciencenews.com\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim\nwww.small-journal.com\nvia nonfluorescent pathways) under the light irradiation. Relatively, PEG-IR-797 NPs heating curve exhibits a better ability to maintain high temperature without a sharp decrease. However, the photothermal effect of IR-797 NPs is a little weaker due to its stronger fluorescence (radiation transition). In order to calculate the photothermal conversion efficiency, the PEG-IR-797 NPs suspensions were continuously irradiated with an 808 nm laser. The laser beam was turned off when the increasing temperature reached a steady state after irradiation for 8 min. Then, the temperature of PEG-IR-797 NPs suspensions was allowed to cool to the room temperature for another 8 min. We also measured the cooling curve of PEG-IR-797 NPs (Figure 2d). Based on the reported method, the time constant (τs) for heat transfer in the system was determined to be 239 s (Figure 2e). The photothermal conversion efficiency of PEG-IR-797 NPs is 56.16% according to the reported method.[14] The photothermal conversion efficiency of the prepared nanoparticle is relatively a high value compared with the generally reported photothermal therapeutic materials, indicating an excellent ability for photothermal therapy (Table S2, Supporting Information). The heating curves of IR-797 NPs with different concentrations were also measured under the same irradiation parameter (Figure S8b, Supporting Information). The results indicate that the temperature increase relies much on the concentration of IR-797 NPs accumulated at the tumor. The photostability of PEG-IR-797 NPs was also investigated with 808 nm laser for five cycles. Each cycle has a laser-on time of 5 min and laser-off time of another 5 min and the PEG-IR-797 NPs shows very steady stability in all five cycles within 50 min (Figure S9, Supporting Information). The size distributions of PEG-IR-797 NPs before and after five cycles 808 nm laser irradiation were also measured by DLS and most of them still maintains at ≈100 nm indicating that the nanoparticles were still in size suitable for tumor accumulation after irradiation (Figure S10, Supporting Information)."
    }, {
      "heading" : "2.3. The Subcellular Location and Cellular Uptake of PEG-IR-797 NPs and IR-797 NPs",
      "text" : "The subcellular location of PEG-IR-797 NPs was investigated using a confocal laser scanning microscope (CLSM). As shown in Figure 2f, most PEG-IR-797 NPs were localized in the cytoplasm of HeLa cells after 24 h incubation and are not observed in nuclei, suggesting that PEG-IR-797 NPs do not enter nuclei. To investigate whether the PEG modification would impact the cellular uptake of IR-797 NPs, the fluorescence of PEG-IR-797 NPs and naked IR-797 NPs in HeLa cells were measured at different incubation times using flow cytometry analysis to quantify in vitro fluorescence intensity (Figure 2g–i). Unexpectedly, there is no significant difference between PEG-IR-797 NPs and IR-797 NPs, which indicates that the PEG coating on the surface of hydrophobic IR-797 NPs does not affect the cellular uptake process of the nanoparticles."
    }, {
      "heading" : "2.4. In Vitro Cytotoxicity and the Cell Death Pathway of PEG-IR-797 NPs",
      "text" : "Due to the strong absorption and high photothermal conversion efficiency, the PEG-IR-797 NPs are expected to be attractive nanomedicine for photothermal therapy on cancers. To\nevaluate the in vitro cytotoxicity of PEG-IR-797 NPs, cell viability under irradiation was measured using MTT assay. HeLa cells were incubated with IR-797 NPs and PEG-IR-797 NPs for 6 h and then irradiated with an 808 nm laser (1 W cm−2) for 5 min. All the groups display the dosage-dependent cytotoxicity (Figure 3a) and their half maximal inhibitory concentrations (IC50) are 3.712 × 10−6 ± 0.209 × 10−6 and 2.431 × 10−6 ± 0.197 × 10−6 m, respectively (Figure 3c). Interestingly, IR-797 NPs and PEG-IR-797 NPs show obvious cytotoxicity without irradiation (Figure 3b). The IC50 values without light irradiation were determined to be 8.101 ± 0.205 × 10−6 m (IR-797 NPs) and 11.908 × 10−6 ± 0.196 × 10−6 m (PEG-IR-797 NPs) (Figure 3c). The cytotoxicities of MCF-7, MCF-7ADR, and A549 cell lines were also measured after incubation with PEGIR-797 NPs in dark conditions. The results also show obvious dark cytotoxicity on these cell lines as that shown with the HeLa cell line, which reveals that PEG-IR-797 NPs could induce death for some common cancer cell lines, even the DOX-resistant cell line (MCF-7ADR) (Figure S11, Supporting Information). We also investigated the dark cytotoxicity of PEG-IR-797 NPs with NIH-3T3 cell line which is the mouse embryonic fibroblasts and dosage-dependent cytotoxicity was observed with the MTT assay indicating that PEG-IR-797 NPs could cause normal cell death (Figure S12, Supporting Information). The results confirm that the IR-797 performs as a cytotoxic chemical, which is a typical character of chemotherapeutic drugs. In order to avoid the cytotoxicity from the possible impurity of the IR-797 molecules, 1H NMR, 13C NMR, and C18 reverse phase UPLC were used to characterize the purity of the IR-797, which had been purified by C18 reverse phase preparative HPLC before use (Figure S13, Supporting Information). The data confirms its purity and indicates the cytotoxicity is due to IR-797 itself. The cell morphologies were also observed after incubated with the IR-797 molecule for 6 h. As is seen from Figure S14 in the Supporting Information, the cell morphology becomes shrank or broken compared with the untreated cells. The change in morphology is solid evidence to demonstrate that IR-797 molecule itself could induce cell death. These results demonstrate that IR-797 molecule has the potential to be a new chemotherapeutic drug.\nWe stained the cells with Calcein acetoxymethylester (Calcine AM) and propidium iodide (PI) after different treatments (1× PBS, only laser, PEG-IR-797 NPs, and PEG-IR-797 NPs + laser) (Figure 3d). The results reveal that, with the PEG-IR-797 NPs treatment and laser irradiation, the number of dead cells is more than that stored with PEG-IR-797 NPs in the dark environment. As controls, the groups were treated with 1× PBS only or with light irradiation only do not show dead cells observed by CLSM, indicating that 808 nm laser irradiation does not harm living cells (green).\nThe IR-797 molecule is an interesting chemical with biofunctions of both intrinsic ability to kill cell and external stimulus induced photothermal therapy, which makes itself as an agent for combination therapy. To further understand the mechanism of its intrinsic ability to kill cell, HeLa cells without irradiation were co-stained with annexin V-fluorescein isothiocyanate (annexin V-FITC) and PI after different incubation time, then tested using the flow cytometry (Figure 3e). Apoptotic cells stained with annexin V-FITC while necrotic cells stained with\nSmall 2019, 1903121\n1903121 (6 of 12)\nwww.advancedsciencenews.com\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim\nwww.small-journal.com\nSmall 2019, 1903121\n1903121 (7 of 12)\nwww.advancedsciencenews.com\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim\nwww.small-journal.com\nPI. After 12 h incubation, all the cells show both annexin V-FITC and PI fluorescence, which indicates the cells in a late stage of apoptosis. When the incubation time was prolonged to 24 h, the fluorescence of PI became stronger, indicating that the percentage of necrotic cells was rising. Thus, the cell death induced by IR-797 molecule is supposed to happen via apoptosis mechanism. To confirm apoptosis pathway, we further studied the expression levels of the apoptosis-related pro-apoptotic proteins and anti-apoptotic proteins in HeLa cells using the western blot analysis after incubation with IR-797 molecules without laser irradiation. It was observed that Hela cells exhibit shrunk morphology after incubation with IR-797 (5 × 10−6 m) for 6 h (Figure S14, Supporting Information), thus, the expression of caspase3, a protein inducing cell shrinking in the apoptosis signal pathway, was examined by western blots analysis. As expected, caspase3 exhibits upregulated expression after incubation with IR-797 for 12 h (Figure 3f). It is well known that the upregulation of caspase3 expression may induce DNA damage, which can further induce the upregulated expression of p53. We further examined the p53 expression with western blots analysis. The western blots result confirmed the upregulated expression of p53 (Figure 3f). Combining the results of both upregulated expressions of caspase3 and p53, we may conclude that the IR-797 is likely to induce the DNA damage and following apoptosis. It is also known that the upregulation of p53 expression can induce the mitochondria damage, thus, a few mitochondria damage related proteins were examined with western blots analysis. The results show that pro-apoptotic proteins like Bax, Bak, and Bad were also sorely upregulated, and the expression levels of anti-apoptotic proteins like Bcl-xL and Bcl-2 were significantly downregulated (Figure S15b, Supporting Information). The results indicate that mitochondria damage might be induced after incubation with IR-797. The above results demonstrate that IR-797 induced apoptosis probably involve in both DNA-damage and mitochondria damage. The joint act on the cell apoptosis procedure can be regarded as an advantage in drug discovery as multitargeted agent has shown its great potential in improving the efficacies and safety.[15] Similar to IR-797 molecules, the PEG-IR-797 NPs also showed upregulation of pro-apoptotic proteins and downregulation of anti-apoptotic proteins in cell because PEG-IR-797 NPs are self-assembled from IR-797 molecules and IR-797 molecules can be released from the PEG-IR-797 NPs (Figure S16, Supporting Information). The in vitro release study demonstrates that IR-797 molecules can be released from PEG-IR-797 NPs in a physiological environment and the cumulative release of IR-797 reaches almost 70% in 48 h (Figure S16, Supporting Information).\nTo further confirm the synergetic effect of photothermalchemo therapy in PEG-IR-797 NPs, we implemented a combination index (CI) determination and isobologram analysis. CI values can provide quantitative information synergetic effect of combination therapy. The CI values lower than, equal to, and higher than 1 represent synergism, additivity, and antagonism, respectively. To measure the cytotoxicity of photothermal therapy alone, HeLa cells were irradiated immediately after adding PEG-IR-797 NPs and then continue incubation for another 5 h (Figure S17a, Supporting Information). It has been found that after a pretreatment of 5 min irradiation under\n808 nm laser, the PEG-IR-797 NPs lose their chemotherapeutic cytotoxicity (Figure S17b, Supporting Information). Therefore, the cytotoxicity was only contributed by the photothermal effect of PEG-IR-797 NPs when adding them into cells and then irradiating cells with 808 nm laser immediately. To measure the cytotoxicity of chemotherapy alone, PEG-IR-797 NPs were incubated with Hela for 6 h in the darkness. All the cytotoxicity was measured by MTT assay. From Figure 3g,h, the CI values are always lower than 1 at a different inhibitory concentration (ICx) from 10% to 90%, which indicates the existence of synergetic effect in photothermal-chemo therapy."
    }, {
      "heading" : "2.5. In Vivo Photoacoustic and Fluorescence Imaging of PEG-IR-797 NPs",
      "text" : "The UV–vis–NIR absorption spectra of PEG-IR-797 NPs slow a maximum between 600 and 850 nm, (mainly in the NIR wavelength range), which benefits in vivo optical imaging with deeper tissue penetration because of the lack of efficient endogenous absorbers.[16] PEG-IR-797 NPs are more favorable to accumulate in tumor tissue than free molecules due to well-known EPR effect that is utilized in preclinical, animal model research, and clinical breast cancer research.[17] The fluorescence signal intensity increases proportionately with more and more PEGIR-797 NPs aggregated in the tumor due to the AIE effect. When a small number of PEG-IR-797 NPs are intravenously injected into HeLa tumor-bearing mice, the fluorescence intensity in tumor significantly increases with prolonged circulation time (Figure 4a,d), showing that PEG-IR-797 NP can serve as a promising contrast agent with high contrast for tumor fluorescence imaging. The peak fluorescence signal of PEG-IR-797 NP in tumor occurs at 12 h post injection. Due to the excellent photothermal effect of PEG-IR-797 NPs, they could also function as photoacoustic imaging. Photoacoustic imaging is based on phonon induced by absorbed light in tissue, which offers highly increased spatial resolution and imaging depth compared to traditional in vivo optical imaging techniques. In our experiment, a small number of PEG-IR-797 NPs (42 nmol, calculated by free IR-797) were intravenously injected into HeLa tumor-bearing Bal b/c mice. In vivo photoacoustic imaging was recorded at different time points post injection. According to Figure 4b,e, the mouse tumor injected with PEG-IR-797 NPs exhibits high-contrast photoacoustic signal and reaching a peak at 12 h post injection, which is consisted of the result of fluorescence imaging. We also studied the semiquantitative fluorescence biodistribution of PEG-IR-797 NPs at the main organs of mice at 12 h post intravenous (i.v.) injection, the time point of maximum accumulation. The result shows that except for tumor, the top two organs obtained PEG-IR-797 NPs at 12 h are the liver and the lung due to the reticulo-endothelial system (RES).[18] The semiquantitative fluorescence biodistribution of free IR-797 molecule was measured as a control. Compared with free IR-797 molecule, a great quantity of PEG-IR-797 NPs is favorable to be accumulated and retained in tumor due to the EPR effect (Figure 4c). In addition, the hemolysis tests show that PEG-IR-797 NPs of concentrations as high as 100 × 10−6 m do not cause hemolysis of red blood cells (RBCs), as the fraction of hemolysis in all concentrations are less than 6% (Figure S18,\nSmall 2019, 1903121\n1903121 (8 of 12)\nwww.advancedsciencenews.com\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim\nwww.small-journal.com\nSupporting Information). To further investigate the biodistribution of PEG-IR-797 NPs and free IR-797, the fluorescence in tumor and main organs of mice were measured at different time points (2, 6, 12, 24 h) post i.v. injection. The results show increased fluorescence intensities of PEG-IR-797 NPs in tumor and several organs, especially liver and spleen. Free IR-797 was eliminated from the body quickly through the kidney and thus little was left in the tumor in long circulation time points (Figure S19a,b, Supporting Information)."
    }, {
      "heading" : "2.6. In Vivo Antitumor Activity of PEG-IR-797 NPs",
      "text" : "Encouraged by the ultrahigh mass extinction coefficient, high photothermal conversion efficiency, and the intrinsic cytotoxicity of PEG-IR-797 NPs, we further investigated their in vivo antitumor activity and took indocyanine green (ICG) as a comparison. ICG is a widely used photothermal agent without observed cytotoxicity in many reported papers. We also measured the in vitro cytotoxicity of ICG and there is no obvious cytotoxicity in dark environment (Figure S20, Supporting Information). When the tumor volume reached ≈100 mm3, HeLa tumor-bearing mice were randomly divided into seven groups (n = 6 per group), group 1: 1 × PBS (pH 7.4), group 2: only laser, group 3: only ICG, group 4: only PEG-IR-797 NPs, group 5: ICG + laser, group 6: PEG-IR-797 NPs + laser, group 7: PEG-IR-797 NPs + 6 h incubation + laser. 50 µL ICG or PEGIR-797 NPs (0.21 × 10−3 m) was directly injected into tumors, respectively. The intratumoral injection strategy was chosen because it has been clinically used for treating primary tumors with advantages over intravenous injection, including concentrating the therapeutic agents at the tumor and minimizing the side effect on the healthy organ. Thus, lots of basic research including photothermal therapy also adopts intratumoral injection and local injection to verify the efficacy of their developed nanomedicine.[9a,19] In this work, the xenograft tumor model was used, which is a model similar to the primary tumor and can thus be treated by intratumoral injection. The nanomedicine in this work integrates functions of both diagnosis and treatment. The tumor-bearing mice were first intravenously injected with the prepared theranostic nanomedicine, which could accumulate at the tumor for tumor imaging and localization by EPR effect. Then, the nanomedicine at a higher treating dose can be injected precisely into the tumor with the premise of diagnosed\nSmall 2019, 1903121\n1903121 (9 of 12)\nwww.advancedsciencenews.com\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim\nwww.small-journal.com\ntumor position in the first step. Mice in groups 5 and 6 were irradiated immediately for 5 min at a power density of 1 W cm−2 after injection to investigate the photothermal effect of ICG and PEG-IR-797 NPs under the 808 nm NIR laser. We have verified that IR-797 molecule is potentially chemotherapeutic without irradiation, thus, PEG-IR-797 NPs that are self-assembled from IR-797 molecule could achieve both photothermal therapy and chemotherapy when delaying the irradiation to leave the chemotherapy to take effect after intratumoral injection. To evaluate the effect of combination therapy, the group 7 were irradiated with an 808 nm laser after 6 h intratumoral injection of PEG-IR-797 NPs, which gives enough time for PEG-IR-797 NPs to penetrate into deep tissue, enter cells, and kill tumor cells (as determined in vitro). The PEG-IR-797 NPs can firstly kill cells as a chemotherapeutic agent and then trigger PTT under irradiation as a synergistic combination therapy. In vivo photothermal heating profiles were recorded using an IR thermal camera (Figure 5a). For mice injected with PEG-IR-797 NPs, tumor temperature gradually increased to ≈62 °C upon exposure to the laser irradiation. This temperature was maintained for 20 min, however, for mice injected with IR-797 NPs, their tumor surface temperature gradually\nSmall 2019, 1903121\n1903121 (10 of 12)\nwww.advancedsciencenews.com\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim\nwww.small-journal.com\nSmall 2019, 1903121\nincreased to the plateau (≈60 °C) and then started to decrease. While the tumor of the mice injected with 1 × PBS under the same laser irradiation shows little increase. Compared with IR797 NPs whose temperature drops after 6 min irradiation, the PEG-IR-797 NPs show a more stable in vivo heating curve and keep the temperature above 62 °C in the whole irradiation procedure (Figure 5b). After various treatments, the tumor volumes and body weight of mice were measured every other day over a period of 21 days (Figure 5c,d). The photographs of a typical mouse undergoing combinational therapy (PEG-IR797 NPs + 6 h incubation + laser) were recorded at the beginning, middle, and end of the treatment (Figure 5f). Finally, the tumors of various treatment groups were collected and weighted at day 21 post treatments (Figure 5e and Figure S21, Supporting Information). The 1× PBS group (group 1), only laser group (group 2), and only ICG group (group 3) show no suppression to the tumor growth. However, the group of mice treated with PEG-IR-797 NPs (group 4) exhibit moderate tumor growth inhibition effect since the PEG-IR-797 NPs can act as a chemotherapeutic agent without irradiation. For the groups with drugs (PEG-IR-797 NPs and ICG) and irradiation (groups 6 and 5, respectively), excellent tumor suppression in the early stage of treatment was observed, however, half mice treated with ICG (group 4) show the aggressive tumor recurrence during the late period of treatment. Due to the ultrahigh mass extinction coefficient, the group of PEG-IR-797 NPs (group 6) has a stronger antitumor effect than ICG group but there is still some small tumor recurrence at the end of the treatment. However, the group of mice receiving PEG-IR-797 NPs + 6 h incubation + laser (group 7) displayed perfect and completed tumor suppression without any recurrence in the whole treatment procedure due to the synergistic effect of photothermal-chemo\n1903121 (11 of 12)\nwww.advancedsciencenews.com\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim\nwww.small-journal.com\ntherapy. Tumors in group 7 suffered from both the toxicity of chemotherapy and hyperthermia of photothermal therapy by one single drug PEG-IR-797 NPs. All groups of HeLa tumorbearing mice were pictured at the end of treatment, the difference of tumor volume is visible by the naked eyes (Figure S22, Supporting Information).\nIn addition, tumor slices were stained with hematoxylin and eosin (H&E) and terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assay. In the H&E assay, the nuclei were stained with hematoxylin as blue and the cytoplasm was stained with eosin as red (Figure 6a). The nuclei stained lightest with shrunken cell morphology in tissue from the PEG-IR-797 NPs + 6 h group (group 7), which indicate that this group had the best therapeutic outcome among all of the groups. The TUNEL staining images show the apoptotic cells in the tumor sections (Figure 6b). Compared with the control groups, the tumors of the group of PEG-IR-797 NPs + 6 h (group 7) showed the most TUNEL-positive cancer cells among all the groups, which indicated that the group of PEG-IR-797 NPs + 6 h exhibited the best antitumor effect. Therefore, our results strongly evidence that the PEG-IR-797 NPs not only possess an excellent photothermal effect due to the ultrahigh mass extinction but also achieve both chemotherapeutic and photothermal therapy to significantly enhance the antitumor effect. We also investigated the H&E staining of the main organs collected from mice after imaging and PTT treatment. There is no obvious damage observed on the main organs in both conditions, indicating relatively good safety of the prepared nanomedicine in both applications (Figures S24 and S25, Supporting Information)."
    }, {
      "heading" : "3. Conclusion",
      "text" : "In conclusion, we report a new class of photothermal agent PEG-IR-797 NPs with ultrahigh mass extinction coefficient. We modify naked IR-797 NPs with an amphiphilic polymer C18PMH-PEG5000 to increase the biocompatibility and stability in water. With high absorbance in the NIR region, the as-prepared PEG-IR-797 NPs displayed not only excellent photothermal effect but also the great ability of photoacoustic imaging for tumor diagnosis. Photoacoustic imaging could offer significantly increased spatial resolution and imaging depth compared to traditional in vivo optical imaging techniques. PEG-IR-797 NPs also possesses an AIE property which is favorable for the high-contrast fluorescence imaging in tumor. Without irradiation, IR-797 molecules can induce the apoptosis through upregulated expressions of pro-apoptotic proteins including p53, caspase3, Bax, Bak, and Bad and the downregulated expressions of anti-apoptotic proteins including Bcl-2 and Bcl-xL, suggesting that IR-797 can serve as a chemotherapeutic agent involving in both DNA damage and mitochondria damage. Thus, PEGIR-797 NPs itself could achieve both chemotherapy and photothermal therapy as a combination therapy. In vivo anti-tumor experiments reveal that the group receiving combination therapy displayed complete tumor ablation and no notable recurrence, however, the control groups of ICG and PEG-IR-797 NPs that are irradiated immediately after intratumoral injection for only the photothermal therapy show tumor recurrence to some extent. Finally, the PEG-IR-797 NPs that possesses multifunctional\nproperties including excellent photothermal effect, instinctive toxicity as a chemotherapeutic drug, high-contrast fluorescence imaging, and photoacoustic imaging. Thus, PEG-IR797 NP is a potential candidate for cancer diagnosis and treatment.\nSupporting Information Supporting Information is available from the Wiley Online Library or from the author."
    }, {
      "heading" : "Acknowledgements",
      "text" : "This work was supported by the National Basic Research Program of China (973 Program) (2013CB933500), Fundamental Research Funds for the Central Universities (Grant No. xzy012019077), China Postdoctoral Science Foundation Grant (Grant No. 2019M653660), the Key Program of the National Natural Science Foundation of China (Grant No. 51533005), the Major Research Plan of the National Natural Science Foundation of China (Grant No. 91333208), and Collaborative Innovation Center of Suzhou Nano Science and Technology, the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), the 111 Project and the Qing Lan Project. All in vivo experiments were performed in compliance with the relevant laws and institutional guidelines and approved by Laboratory Animal Center of Soochow University."
    }, {
      "heading" : "Conflict of Interest",
      "text" : "The authors declare no conflict of interest."
    }, {
      "heading" : "Keywords",
      "text" : "combination therapy, photoacoustic imaging, photothermal therapy, theranostics, ultrahigh mass extinction coefficient\nReceived: June 16, 2019 Revised: July 16, 2019\nPublished online:\n[1] Y. Liu, P. Bhattarai, Z. Dai, X. Chen, Chem. Soc. Rev. 2019, 48, 2053. [2] a) W. Y. Zhen, Y. Liu, L. Lin, J. Bai, X. D. Jia, H. Y. Tian, X. Jiang, Angew. Chem., Int. Ed. 2018, 57, 10309; b) H. Lin, S. S. Gao, C. Dai, Y. Chen, J. L. Shi, J. Am. Chem. Soc. 2017, 139, 16235; c) F. Gong, L. Cheng, N. L. Yang, Q. T. Jin, L. L. Tian, M. Y. Wang, Y. G. Li, Z. Liu, Nano Lett. 2018, 18, 6037. [3] a) J. Cui, R. Jiang, C. Guo, X. Bai, S. Xu, L. Wang, J. Am. Chem. Soc. 2018, 140, 5890; b) Y. J. Zhang, R. Sha, L. Zhang, W. B. Zhang, P. P. Jin, W. G. Xu, J. X. Ding, J. Lin, J. Qian, G. Y. Yao, R. Zhang, F. C. Luo, J. Zeng, J. Cao, L. P. Wen, Nat. Commun. 2018, 9, 4236; c) Y. J. Liu, Z. Yang, X. L. Huang, G. C. Yu, S. Wang, Z. J. Zhou, Z. Y. Shen, W. P. Fan, Y. Liu, M. Davisson, H. Kalish, G. Niu, Z. H. Nie, X. Y. Chen, ACS Nano 2018, 12, 8129. [4] a) N. Li, Q. Q. Sun, Z. Z. Yu, X. N. Gao, W. Pan, X. Y. Wan, B. Tang, ACS Nano 2018, 12, 5197; b) C. L. Tan, Z. C. Lai, H. Zhang, Adv. Mater. 2017, 29, 1701392; c) Q. Lei, S. B. Wang, J. J. Hu, Y. X. Lin, C. H. Zhu, L. Rong, X. Z. Zhang, ACS Nano 2017, 11, 7201; d) B. W. Yang, Y. Chen, J. L. Shi, Chem 2018, 4, 1284; e) R. Kurapati, K. Kostarelos, M. Prato, A. Bianco, Adv. Mater. 2016, 28, 6052; f) F. F. An, X. H. Zhang, Theranostics 2017, 7, 3667.\nSmall 2019, 1903121\n1903121 (12 of 12)\nwww.advancedsciencenews.com\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim\nwww.small-journal.com\nSmall 2019, 1903121\n[5] a) C. M. Mei, N. Wang, X. Q. Zhu, K. H. Wong, T. F. Chen, Adv. Funct. Mater. 2018, 28, 1805225; b) J. Z. Liu, J. Dong, T. Zhang, Q. Peng, J. Controlled Release 2018, 286, 64. [6] a) Q. L. Zou, M. Abbas, L. Y. Zhao, S. K. Li, G. Z. Shen, X. H. Yan, J. Am. Chem. Soc. 2017, 139, 1921; b) N. Alifu, A. Zebibula, J. Qi, H. Zhang, C. Sun, X. Yu, D. Xue, J. W. Y. Lam, G. Li, J. Qian, B. Z. Tang, ACS Nano 2018, 12, 11282; c) Y. Y. Jiang, J. C. Li, X. Zhen, C. Xie, K. Y. Pu, Adv. Mater. 2018, 30, 1705980; d) B. Guo, Z. H. Sheng, D. H. Hu, C. B. Liu, H. R. Zheng, B. Liu, Adv. Mater. 2018, 30, 1802591; e) H. Wang, J. Chang, M. Shi, W. Pan, N. Li, B. Tang, Angew. Chem., Int. Ed. 2019, 58, 1057; f) X. Zhen, J. J. Zhang, J. G. Huang, C. Xie, Q. Q. Miao, K. Y. Pu, Angew. Chem., Int. Ed. 2018, 57, 7804; g) H. S. Jung, P. Verwilst, A. Sharma, J. Shin, J. L. Sessler, J. S. Kim, Chem. Soc. Rev. 2018, 47, 2280. [7] a) X. Wang, Y. C. Ma, X. Sheng, Y. C. Wang, H. X. Xu, Nano Lett. 2018, 18, 2217; b) J. N. Xuan, Z. Q. Wang, Y. Y. Chen, D. J. Liang, L. Cheng, X. J. Yang, Z. Liu, R. Z. Ma, T. Sasaki, F. X. Geng, Angew. Chem., Int. Ed. 2016, 55, 14569; c) H. Lin, X. G. Wang, L. D. Yu, Y. Chen, J. L. Shi, Nano Lett. 2017, 17, 384. [8] a) J. Y. Zeng, M. K. Zhang, M. Y. Peng, D. Gong, X. Z. Zhang, Adv. Funct. Mater. 2018, 28, 1705451; b) W. S. Chen, K. Zeng, H. Liu, J. Ouyang, L. Q. Wang, Y. Liu, H. Wang, L. Deng, Y. N. Liu, Adv. Funct. Mater. 2017, 27, 1605795; c) Y. W. Chen, Y. L. Su, S. H. Hu, S. Y. Chen, Adv. Drug Delivery Rev. 2016, 105, 190. [9] a) J. Conde, N. Oliva, Y. Zhang, N. Artzi, Nat. Mater. 2016, 15, 1128; b) L. Z. Zhao, W. Yuan, H. P. Tham, H. Z. Chen, P. Y. Xing, H. J. Xiang, X. Yao, X. C. Qiu, Y. Dai, L. L. Zhu, F. Y. Li, Y. L. Zhao, Small 2017, 13, 1700963. [10] a) W. Huang, Y. Y. Huang, Y. Y. You, T. Q. Nie, T. F. Chen, Adv. Funct. Mater. 2017, 27, 1701388; b) D. D. Wang, H. F. Dong, M. Li, Y. Cao, F. Yang, K. Zhang, W. H. Dai, C. Wang, T. X. J. Zhang, ACS Nano 2018, 12, 5241; c) W. S. Chen, J. Ouyang, H. Liu, M. Chen, K. Zeng,\nJ. P. Sheng, Z. J. Liu, Y. J. Han, L. Q. Wang, J. Li, L. Deng, Y. N. Liu, S. J. Guo, Adv. Mater. 2017, 29, 1603864; d) N. Ma, M. K. Zhang, X. S. Wang, L. Zhang, J. Feng, X. Z. Zhang, Adv. Funct. Mater. 2018, 28, 1801139. [11] M. Zhou, X. Zhang, Y. Yang, Z. Liu, B. Tian, J. Jie, X. Zhang, Biomaterials 2013, 34, 8960. [12] a) S. Stapleton, D. Jaffray, M. Milosevic, Adv. Drug Delivery Rev. 2017, 109, 119; b) T. Ojha, V. Pathak, Y. Shi, W. E. Hennink, C. T. W. Moonen, G. Storm, F. Kiessling, T. Lammers, Adv. Drug Delivery Rev. 2017, 119, 44. [13] a) F. I. Tanczos, J. Chem. Phys. 1956, 25, 439; b) K. E. Schultz, D. J. Russell, C. B. Harris, J. Chem. Phys. 1992, 97, 5431. [14] J. F. Zhang, C. X. Yang, R. Zhang, R. Chen, Z. Y. Zhang, W. J. Zhang, S. H. Peng, X. Y. Chen, G. Liu, C. S. Hsu, C. S. Lee, Adv. Funct. Mater. 2017, 27, 1605094. [15] J. Jia, F. Zhu, X. Ma, Z. W. Cao, Y. X. Li, Y. Z. Chen, Nat. Rev. Drug Discovery 2009, 8, 111. [16] a) R. Vankayala, K. C. Hwang, Adv. Mater. 2018, 30, 1706320; b) G. S. Hong, A. L. Antaris, H. J. Dai, Nat. Biomed. Eng. 2017, 1, 0010. [17] H. Lee, A. F. Shields, B. A. Siegel, K. D. Miller, I. Krop, C. X. Ma, P. M. LoRusso, P. N. Munster, K. Campbell, D. F. Gaddy, S. C. Leonard, E. Geretti, S. J. Blocker, D. B. Kirpotin, V. Moyo, T. J. Wickham, B. S. Hendriks, Clin. Cancer Res. 2017, 23, 4190. [18] J. Bourquin, A. Milosevic, D. Hauser, R. Lehner, F. Blank, A. Petri-Fink, B. Rothen-Rutishauser, Adv. Mater. 2018, 30, 1704307. [19] a) C. Zhang, D. Ni, Y. Liu, H. Yao, W. Bu, J. Shi, Nat. Nanotechnol. 2017, 12, 378; b) N. Gong, X. Ma, X. Ye, Q. Zhou, X. Chen, X. Tan, S. Yao, S. Huo, T. Zhang, S. Chen, X. Teng, X. Hu, J. Yu, Y. Gan, H. Jiang, J. Li, X.-J. Liang, Nat. Nanotechnol. 2019, 14, 379; c) Y. Hu, C. Chi, S. Wang, L. Wang, P. Liang, F. Liu, W. Shang, W. Wang, F. Zhang, S. Li, H. Shen, X. Yu, H. Liu, J. Tian, Adv. Mater. 2017, 29, 1700448."
    } ],
    "references" : [ {
      "title" : "Chem",
      "author" : [ "Y. Liu", "P. Bhattarai", "Z. Dai", "X. Chen" ],
      "venue" : "Soc. Rev. 2019, 48",
      "citeRegEx" : "1",
      "shortCiteRegEx" : null,
      "year" : 2053
    } ],
    "referenceMentions" : [ {
      "referenceID" : 0,
      "context" : "It has been confirmed that hyperthermia is lethal for living cells when the temperature rises over 50 °C, thus, photothermal therapy (PTT) has attracted much attention in recent years.[1,2] Up till now, many nanomaterials, such as noble metal (e.",
      "startOffset" : 184,
      "endOffset" : 189
    } ],
    "year" : 2019,
    "abstractText" : "Dr. F.-F. An Institute of Medical Engineering Department of Biophysics School of Basic Medical Science Health Science Center Xi’an Jiaotong University No.76 Yanta West Road, Xi’an 710061, Shaanxi, P. R. China E-mail: anfeifei@xjtu.edu.cn Prof. Z. Yu Guangdong Provincial Key Laboratory of New Drug Screening School of Pharmaceutical Sciences Southern Medical University Guangzhou 510515, P. R. China E-mail: yuzq@smu.edu.cn Prof. R. Ting Department of Radiology Molecular Imaging Innovations Institute Weill Cornell Medicine New York, NY 10065, USA DOI: 10.1002/smll.201903121",
    "creator" : "Adobe InDesign CS6 (Macintosh)"
  }
}